Newbridge Financial Services Group Inc. Acquires Shares of 249 iShares Biotechnology ETF (NASDAQ:IBB)

Newbridge Financial Services Group Inc. acquired a new stake in iShares Biotechnology ETF (NASDAQ:IBB) during the 4th quarter, Holdings Channel reports. The institutional investor acquired 249 shares of the financial services provider’s stock, valued at approximately $33,000.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Darwin Wealth Management LLC acquired a new position in shares of iShares Biotechnology ETF in the third quarter valued at approximately $29,000. Highline Wealth Partners LLC acquired a new position in shares of iShares Biotechnology ETF in the third quarter valued at approximately $30,000. HHM Wealth Advisors LLC grew its position in shares of iShares Biotechnology ETF by 200.0% in the fourth quarter. HHM Wealth Advisors LLC now owns 225 shares of the financial services provider’s stock valued at $30,000 after purchasing an additional 150 shares during the last quarter. Hager Investment Management Services LLC acquired a new position in shares of iShares Biotechnology ETF in the fourth quarter valued at approximately $34,000. Finally, Ashton Thomas Securities LLC acquired a new position in shares of iShares Biotechnology ETF in the third quarter valued at approximately $36,000. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Down 1.4 %

iShares Biotechnology ETF stock opened at $134.24 on Wednesday. iShares Biotechnology ETF has a 12 month low of $123.60 and a 12 month high of $150.57. The stock’s 50 day moving average is $135.99 and its 200-day moving average is $141.17.

iShares Biotechnology ETF Cuts Dividend

The business also recently declared a dividend, which was paid on Friday, December 20th. Investors of record on Tuesday, December 17th were given a dividend of $0.0624 per share. The ex-dividend date was Tuesday, December 17th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.